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Abstract
Aims/hypothesis Our aim was to determine whether quantitative retinal traits in people with type 2 diabetes are independently
associated with incident major cardiovascular events including CHD and stroke.
Methods A total of 1066 men and women with type 2 diabetes, aged 65–74 years, were followed up over 8 years in the population-
based Edinburgh Type 2 Diabetes Study. Using retinal photographs taken at baseline and specialist software, a number of quan-
titative retinal traits were measured, including arteriolar and venular widths and tortuosity as well as fractal dimension (a measure of
the branching pattern complexity of the retinal vasculature network). Incident CHD events occurring during follow-up included fatal
and non-fatal myocardial infarction, first episodes of angina and coronary interventions for CHD. Incident cerebrovascular events
included fatal and non-fatal stroke or transient ischaemic attack. Cox proportional hazard regression analyses were performed to
identify the association of the retinal traits with cardiovascular events in the population with retinal data available (n = 1028).
Results A total of 200 participants had an incident cardiovascular event (139 CHD and 61 cerebrovascular events). Following
adjustment for age and sex, arteriolar tortuosity and fractal dimension were associated with cerebrovascular events (HR 1.27 [95%
CI 1.02, 1.58] and HR 0.74 [95% CI 0.57, 0.95], respectively), including with stroke alone (HR 1.30 [95% CI 1.01, 1.66] and HR
0.73 [95% CI 0.56, 0.97], respectively). These associations persisted after further adjustment for established cardiovascular risk
factors (HR 1.26 [95% CI 1.01, 1.58] and HR 0.73 [95% CI 0.56, 0.94], respectively). Associations generally reduced in strength
after a final adjustment for the presence of diabetic retinopathy, but the association of fractal dimension with incident cerebrovas-
cular events and stroke retained statistical significance (HR 0.73 [95% CI 0.57, 0.95] and HR 0.72 [95% CI 0.54, 0.97], respec-
tively). Associations of retinal traits with CHD were generally weak and showed no evidence of statistical significance.
Conclusions/interpretation Arteriolar tortuosity and fractal dimension were associated with incident cerebrovascular events,
independent of a wide range of traditional cardiovascular risk factors including diabetic retinopathy. These findings suggest
potential for measurements of early retinal vasculature change to aid in the identification of people with type 2 diabetes who are at
increased risk from stroke.
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People with type 2 diabetes have a well-established increased
risk of CVD, including CHD, peripheral arterial disease and
cerebrovascular disease [1, 2]. Despite the substantial interest
in evaluating cardiovascular risk at an individual level, there is
no general consensus on which biomarkers are most useful for
predicting the development of CVD in this population.
Current ‘traditional’ biomarkers and CVD risk prediction
models in people with type 2 diabetes lack accuracy [3], indi-
cating a need for novel biomarkers that predict individual risk
in this population.
Recent studies indicate the potential of novel retinal
biomarkers, related to measurable morphology of the retinal
vasculature observable in fundus camera images and analysed
by computer-based platforms, to assess risk of major cardio-
vascular events in type 2 diabetes [4, 5]. With advances in
technology, retinal imaging is reproducible, radiation free,
and relatively inexpensive. Changes in the retinal microvas-
culature are associated with vascular risk factors and micro-
vascular complications in healthy individuals and in individ-
uals with type 2 diabetes, such as hypertension and diabetic
retinopathy [5, 6]. These changes in retinal microcirculation
have also been associated with the presence of major athero-
sclerotic cardiovascular outcomes, including CHD [7] and
stroke [8, 9]. However, the majority of studies to date have
been cross-sectional, limiting the findings in relation to the
assessment of the temporal relationship between biomarkers
and subsequent onset of cardiovascular events. Moreover,
research in this area, specifically in people with type 2 diabe-
tes, is extremely limited.
A wide range of retinal vessel traits have been investigated
[10], including measurements of arteriolar and venular diam-
eters; branching complexity of the vascular network or pattern
quantified through the calculation of fractal dimension; and
tortuosity which puts a numerical value to how much a vessel
twists and turns.
In light of the potential for retinal vascular traits to predict
development of cardiovascular events, and the current lack of
prospective studies, particularly in people with type 2 diabe-
tes, the aim of the current study was to determine the associ-
ation between quantitative retinal traits and subsequent devel-




The Edinburgh Type 2 Diabetes Study (ET2DS) is a popula-
tion-based, prospective cohort of 1066 men and women aged
between 60 and 75 years at baseline (2006–2007) with an
established diagnosis of type 2 diabetes, living in the
Lothian region of Scotland, UK. Details of the study protocol
have been published previously [11]. Participants were
randomly selected by sex and 5 year age bands from the
Lothian diabetes register, a comprehensive database of people
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with type 2 diabetes living in Lothian. Of the 5454 individuals
who were invited to participate, 1066 were recruited to the
study and were shown subsequently to be largely representa-
tive of the target population of all older men and women with
type 2 diabetes in Lothian [12]. Participants attended baseline
research clinics for physical examination and retinal photog-
raphy, and were subsequently followed up at 4 and 8 years for
cardiovascular events. The ET2DS was granted ethical
approval by the Lothian Medical Research Ethics
Committee, and all participants gave written informed
consent.
Baseline physical examination
At the main baseline ET2DS clinic, demographic, medical
history and clinical variables were collected. A self-
completionmedical questionnaire was completed and brachial
BP was measured. Fasting venous blood was obtained for
analysis of fasting glucose, total cholesterol, HDL-cholesterol,
HbA1c and serum creatinine. Total cholesterol, HDL-choles-
terol, HbA1c and creatinine were all measured using Vitros
Fusion Chemistry System (Ortho Clinical Diagnostics, UK)
at the Western General Hospital, Edinburgh, UK. Plasma C-
reactive protein (CRP) was measured at the University
Department of Medicine, Glasgow Royal Infirmary, UK,
using a high-sensitivity immunonephelometric assay. eGFR
was calculated from creatinine results using the Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI)
equation.
Retinal photography and retinopathy grading
Retinal images were collected at baseline in the main ophthal-
mology department for NHS Lothian by a single specially
trained medical photographer. Of the 1046 ET2DS partici-
pants who underwent retinal examinations [13], two were
subsequently excluded from analyses as they did not have
gradable photographs, leaving 1044 participants. During the
assessment, participants had 1% tropicamide drops instilled
into both eyes to allow pupillary dilatation before having the
image captured. If, on inspection of the pupils, dilatation was
insufficient, a further 1% tropicamide dose was given. Retinal
images were taken at 45° angle using a digital fundus camera
(TOPCON TRC-NW8, Topcon Optical Company, Tokyo,
Japan). Standard 7-field non-stereoscopic retinal colour
photographs were taken, and assessed for the presence of
diabetic retinopathy. Two trained optometrists graded all the
photographs, working independently and according to the
scale described by the Early Treatment Diabetic Retinopathy
Study research group [14, 15]. For each eye, the maximum
grade in any of the seven photographic fields was determined
for each of the characteristic lesions of diabetic retinopathy
and was used in defining the final retinopathy levels, varying
from level 10 (no retinopathy) to level 81 (advanced prolifer-
ative retinopathy). Any discrepancies between the scores
assigned by the two graders were resolved through discussion
between the graders with any unresolved discrepancies being
reviewed and arbitrated by an ophthalmologist. Diabetic reti-
nopathy was classified as a binary variable for the purpose of
the current analysis. Any degree of diabetic retinopathy (e.g.
mild, moderate and/or severe) were included as cases.
Measurement of retinal quantitative traits
For each participant, the best quality central image (either
right or left side) was selected to be included in the analysis
of quantitative retinal traits. Vascular Assessment and
Measurement Platform for Images of the Retina
(VAMPIRE) version 3.1 software [16] was used to quantify
retinal vessel traits including the widths of the six longest
arterioles to calculate the central retinal arteriolar equivalent
(CRAE); the six longest venules to calculate the central retinal
venous equivalent (CRVE); and the ratio of these two param-
eters to give the arteriovenous ratio (AVR). These parameters
are located in zone B. Measurement of these vessel widths is
based on cross-sectional width at regular intervals along the
length of a vessel segment (electronic supplementary material
[ESM] Fig. 1).
Arteriolar tortuosity (mean measurement from the six
thickest arterioles in a single participant) and venular tortuos-
ity (mean measurement from the six thickest venules in a
single participant) were taken from zone C. This is a ring-
shaped area located between 0.5 and 1 disc diameter’s
distance from the optic disc. The analyses of global vascula-
ture (arterioles and venules) extracted the multifractal dimen-
sion, which is an extension of fractals in two-dimensional
space using the sand-box method and has been described else-
where [17]. For the purpose of this study, multifractal dimen-
sion will be referred to as fractal dimension. Obtaining fractal
dimensions involved automatic segmentation classifying each
pixel of the retinal image as vessel and non-vessel to produce a
segmented map of the retinal vasculature. In a step prior to
fractal analysis, computationally segmented images were
inspected and artefacts (e.g. low contrast) caused by dust on
the camera were corrected or removed. This iterative deletion
of the pixels produced skeletonised images which are required
to obtain fractal dimension. These analyses were performed
after processing and stored the initial results.
To evaluate reliability and agreement of the measured reti-
nal traits, interclass correlation coefficients were computed to
measure intra- and inter-grader agreement [18]. Depending on
the precise retinal area from which readings are taken, intra-
grader and inter-grader correlations for these retinal traits




Prevalent CVD at baseline The presence of CVD at baseline
was determined using a combination of self-report in the
standardised ET2DS self-completion questionnaire, the
WHO chest pain questionnaire, a 12-lead ECG coded using
the Minnesota coding system and linkage to hospital
discharge data from the information service division of NHS
Scotland (ISD). Presence of CVD included myocardial infarc-
tion, angina, stroke, transient ischaemic attack (TIA) and/or
coronary intervention defined according to previously report-
ed criteria which were based on these sources of information
[11]. Additionally, when necessary, clinical notes from gener-
al practices and hospitals were obtained to confirm or refute a
possible diagnosis of CVD. The presence of prevalent CVD
was included as binary variable, categorising any type of
event as cases.
Incident cardiovascular events during follow-up Incident and
recurrent cardiovascular events were recorded at the 4 year
follow-up phase of the ET2DS and after 8 years, based on
the same predefined criteria as at baseline. At year 4, events
were identified using self-completion questionnaires complet-
ed in the 4 year research clinic, questionnaires from general
practitioners (GPs) (including from clinic non-attenders),
ECGs and record linkage to hospital discharge data from
ISD. If necessary, clinical notes from the hospital were
searched to confirm clinical information. After 8 years from
baseline, repeat record linkage was undertaken to identify
further cardiovascular events.
Specific criteria used to define an incident cardiovascular
event (fatal and non-fatal) were as follows. Myocardial infarc-
tion: ICD-10 (International Classification of Diseases, 10th
revision) code for new myocardial infarction (I21-I23, I25.2)
on discharge/death record, dated after baseline, confirmed by
self-reported doctor diagnosis of myocardial infarction; posi-
tive WHO chest pain questionnaire for myocardial infarction;
report of myocardial infarction on GP questionnaire; new
ECG changes; or inspection of clinical notes. Angina: (1)
ICD-10 code for angina (I20, I25) as primary diagnosis on
hospital discharge record, dated after baseline, with no previ-
ous indication of angina; or (2) at least two of (a) self-reported
doctor diagnosis of angina or new angina medication since
baseline, (b) ECG codes for ischaemia that were not present
at baseline and (c) positive WHO chest pain questionnaire.
Fatal CHD: ICD-10 code for CHD (I209, I249, I258, I259)
as primary cause of death. Stroke: (1) ICD-10 code for stroke
(I61, I63, I66, I679, I694) as primary diagnosis on discharge/
death record, dated after baseline, or (2) self-report of stroke or
non-primary ICD-10 discharge/death code for stroke dated
after baseline, both confirmed on scrutiny of clinical notes.
TIA: (1) ICD-10 code for TIA (G45) as primary diagnosis
on discharge record; or (2) self-report of stroke or non-
primary ICD-10 discharge code for stroke or TIA dated after
baseline, confirmed as TIA on scrutiny of clinical notes.
Coronary intervention: OPCS operation code for coronary
intervention (K40-K44) on discharge record.
Statistical analyses
Initially, all variables were examined for outliers/extreme
values and missing values prior to undertaking any statistical
analyses. All the continuous variables were assessed visually
for normality using histograms in an effort to address potential
bias. Those variables that were not normally distributed were
transformed using logarithm base e (loge). Rank transforma-
tion was used to normalise the distribution of fractal dimen-
sion, because fractal dimension is a unitless feature of struc-
tural complexity. In regression analyses, different units and
different scales are often used. Given that this may cause diffi-
culty in interpreting the results and comparison across find-
ings, values were standardised using the mean and SD to
produce a scaled variable. This maintains the same relation-
ship to one another as the unscaled variable. Univariable anal-
yses of established cardiovascular risk factors and quantitative
retinal traits were run to detect differences between those with
incident cardiovascular event during follow-up and those
without incident cardiovascular events. The χ2 test was used
to explore relationships between dichotomous variables. The
unpaired t test or Mann–WhitneyU test were applied to assess
the differences of continuous variables in people with incident
and without incident cardiovascular events. Results are
expressed as means (± SD) unless otherwise stated.
Prospective statistical analysis Cox proportional hazard
survival regression analyses were used to examine the associ-
ation of the baseline quantitative retinal traits with incident
cardiovascular events. Variables were selected as possible
confounders to build different models and assess the strength
and independence of the association of the quantitative retinal
traits with incidental cardiovascular outcomes. Covariables
were selected according to the significant univariate associa-
tion results and also to reflect traditional risk factors described
previously in the literature. HRs for continuous variables
relate to a 1 SD increase. False discovery rates were calculated
to understand the rate of type 1 errors when carrying out
multiple tests. Event-free survival curves for cerebrovascular
events were developed using the Kaplan–Meier method.
Difference of incidence between groups was assessed by
logrank tests.
Quantitative retinal traits found to be independently asso-
ciated with incident events were evaluated, in combination
with traditional cardiovascular risk factors, using concordance
statistic (or C statistic) to see if the model improved, to eval-
uate the discriminative ability of the models, before and after
addition of the retinal trait. Calibration was assessed using an
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extension of the Hosmer–Lemeshow χ2 statistic to test
goodness-of-fit (p value >0.05 indicates good calibration).
Statistical analyses were carried out using SPSS (version
23.0; IBM, Armonk, NY, USA) and R (R: A language and
environment for statistical computing, version 3.1.1, Vienna,
Austria). A p value of less than 0.05 was taken as statistically
significant.
Results
The baseline demographic, vascular disease and retinal trait
characteristics of the ET2DS population are summarised in
Table 1. A total of 547 (51.31%) participants were male and
the mean age was 67.9 years at baseline. Prevalence of prior
myocardial infarction, angina, stroke, TIA and coronary inter-
vention were 150 (14.1%), 298 (27.5%), 62 (5.8%), 31 (2.9%)
and 110 (10.3%), respectively. The prevalence of diabetic
retinopathy at baseline was 31.8%.
In the total population with retinal data available (n = 1028)
and after a mean follow-up of 7.2 years (range 0.05–8.5, medi-
an 7.8 years), the number of first incident cardiovascular
events was 200 (19%), including 60 fatal/non-fatal myocardial
infarction, 36 angina, 49 stroke, 12 TIA, 26 coronary inter-
vention and 17 fatal CHD.
A comparison of baseline variables according to whether or
not participants developed an incident cardiovascular event is
shown in Table 2. As expected, participants with incident
cardiovascular events were more likely to be male, were older,
had lower eGFR and HDL-cholesterol levels, longer diabetes
duration, higher HbA1c, and were more likely to have preva-
lent cardiovascular disease and diabetic retinopathy.
Participants on anti-hypertensive medication and those using
medication for glucose control were more likely to develop
incident cardiovascular events.
Although there were no statistically significant differences
between the groups (e.g. non-incident cardiovascular and inci-
dent cardiovascular), the direction of non-significant differ-
ences can be seen, i.e. participants with incident events tended
to have narrower arterioles (as indicated by a decreased
CRAE), narrower venules (decreased CRVE), increased arte-
riolar tortuosity, increased venular tortuosity and decreased
fractal dimension (indicating a sparser and less complex
vasculature). These details are described in Table 2.
Multivariable Cox regression model findings are shown in
Table 3 for vessel widths, and Table 4 for arteriolar tortuosity
and fractal dimension. Significant models using tertiles of
arteriolar tortuosity and tertiles for fractal dimension are
shown in Tables 5 and 6, respectively.
No evidence of statistically significant associations of
composite cardiovascular, coronary or cerebrovascular events
with changes in vessel widths were found (i.e. AVR, CRAE or
CRVE) (Table 3). Supplemental analyses explored the









Plasma glucose (mmol/l) 7.5±2.1





eGFR (ml min−1 [1.73 m]−2) 78.3±23.1
CRP (mg/l) 1.9 (0.9–4.4)
Duration of diabetes (years) 6.0±8.0
Current diabetes treatment
Diet only 200 (18.8)
Tablets 675 (63.4)
Insulin ± tablets 190 (17.8)
Anti-hypertensive medication 872 (81.8)
Lipid-lowering medication 912 (85.6)
Smoking
Current smoker 153 (14.4)
Ex-smoker 499 (46.8)
Never smoker 414 (38.8)
CV eventa












Arteriolar tortuosity 3.9 (0.13–279.0)b
Venular tortuosity 4.6 (0.26–410.0)b
Fractal dimension 1.8 (1.5–1.9)
Data are presented as mean ± SD, median (IQR), or n (%)
a Note that there is overlap between these event subgroups
bValues 10−5
CV, cardiovascular; px, pixels
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association of quantitative retinal traits with composite severe
cardiovascular events only (myocardial infarction, coronary
intervention, fatal ischaemic heart disease and stroke). There
was a sex interaction for AVR (p = 0.007), CRAE (p = 0.008),
CRVE (p = 0.006), also seen for arteriolar tortuosity (p =
0.007), venular tortuosity (p = 0.006) and fractal dimension
(p = 0.005). Findings ofmultivariate analyses using this small-
er group of composite severe cardiovascular events were not
statistically significant (ESM Table 1).
There were no statistically significant associations for arte-
riolar or venular tortuosity measures with coronary events and
no association between venular tortuosity and cerebrovascular
Table 2 Baseline characteristics
of individuals with incident CV
events and no events (n = 1028






Age (years) 68.9±4.2 67.7±4.2 <0.001
Sex (male) 118 (59.0) 410 (49.5) <0.01
BMI (kg/m2) 31.9±5.6 31.3±5.7 0.23
BP
Systolic (mmHg) 134.9±19.1 132.8±15.6 0.10
Diastolic (mmHg) 69.1±9.8 69.0±8.8 0.92
Plasma glucose (mmol/l) 7.8±2.6 7.5±1.9 0.13
Total cholesterol (mmol/l) 4.4±1.0 4.3±0.9 0.06
HbA1c
(mmol/mol) 60±11 56±8.6 <0.01
(%) 7.6±1.3 7.3±1.0 <0.01
HDL-cholesterol (mmol/l) 1.2±0.3 1.3±0.4 <0.0001
eGFR (ml min−1 [1.73 m]−2) 70.4±23.9 80.0±22.6 <0.0001
CRP (mg/l) 4.0 (1.2–4.6) 3.9 (0.8–4.4) 0.76
Duration of diabetes (years) 9.3±6.8 7.8±6.3 <0.01
Current diabetes treatment a
Oral diabetes medication 142 (71.0) 607 (73.3) 0.49
Insulin ± tablets 57 (28.5) 128 (15.4) <0.0001
Anti-hypertensive medication 26 (13.0) 154 (18.6) <0.05
Lipid-lowering medication 21 (10.5) 122 (14.7) 0.75
Smoking
Current smoker 28 (14.0) 118 (14.2) 0.78
Ex-smoker 100 (50) 385 (46.5) 0.35
Never smoker 72 (36.0) 325 (39.3) 0.64
CVD at baseline 116 (58.0) 248 (30.0) <0.0001
Diabetic retinopathy
None 118 (59.0) 587 (70.9) <0.01
Present 86 (43.0) 253 (30.6) <0.01
Quantitative retinal traits
AVR 0.74±0.7 0.74±0.8 0.34
CRAE 32.67±3.7 33.11±3.9 0.14
CRVE 44.46±4.9 44.72±5.0 0.50
Arteriolar tortuosity −10.01±1.2 −10.09±1.1 0.40
Venular tortuosity −9.92±1.0 −9.97±0.9 0.55
Fractal dimension 1.7±0.1 1.8±0.1 0.08
Data are presented as mean ± SD, median (IQR), or n (%)
Values for arteriolar and venular tortuosity were normalised using loge transformation
Rank transformation was used to normalise the data of the fractal dimension variable
a Note there were 93 (11.2%) participants on diet only with no incident event
CV, cardiovascular
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events (including stroke). However, increased arteriolar tortu-
osity was associated with incident cerebrovascular events
(Table 4); analyses between sex and retinal traits and sex,
age and retinal traits were evaluated for any effect modifica-
tion. The sex interaction was statistically non-significant for
cerebrovascular events. Estimated HR for sex was slightly
increased in men compared with women. In unadjusted
models, for 1 SD increase in the arteriolar tortuosity there
was a 26% risk increase in cerebrovascular events, remaining
significant after adjustment for sex, age, duration of diabetes,
systolic BP, HbA1c, total cholesterol, HDL-cholesterol,
smoking, prevalent cardiovascular events and renal function.
The association was attenuated in the fully adjusted model
including diabetic retinopathy and CRP.
Fractal dimension also showed statistically significant
associations with cerebrovascular events and stroke
(Table 4). In the unadjusted models, for a 1 SD increase in
the fractal dimension, there was a decrease in risk of cerebro-
vascular events by 73% and stroke by 72%. These associa-
tions remained significant after full multivariable adjustment,
including for diabetic retinopathy and CRP.
Prediction analyses for arteriolar tortuosity and
fractal dimension
Arteriolar tortuosity and fractal dimension were added, separate-
ly, to a base model with traditional vascular risk factors for
cerebrovascular events. Regarding cerebrovascular events, for
arteriolar tortuosity, the discriminative ability (C statistic) of the
resultant model improved modestly from 0.705 to 0.723. For
fractal dimension, the C statistic correspondingly increased from
0.705 to 0.725. For diabetic retinopathy, the C statistic resultant
model improved minimally from 0.705 to 0.706. Regarding
stroke, findings were similar for both the addition of arteriolar
tortuosity to the base model (C statistic improved modestly from
0.706 to 0.723) and for the addition of fractal dimension (C
statistic increase from 0.706 to 0.727). Corresponding
goodness-of-fit analysis for the base model including vascular
risk factors for cerebrovascular events showed good calibration
(p = 0.12). Likewise, models including arteriolar tortuosity (p =
0.53) and fractal dimension (p = 0.59) were well calibrated.
Findings were similar for stroke models, with good calibration
found for the base model (p = 0.58) and those with arteriolar
tortuosity (p = 0.26) and fractal dimension (p = 0.93).
The incidence (i.e. one minus survival probability) of cere-
brovascular events of the study population in relation to the
different tertiles of arteriolar tortuosity (logrank p = 0.003) and
fractal dimension (logrank p = 0.015) is shown in Figs 1 and 2,
respectively.
Discussion
To our knowledge this is the first study to examine a compre-
hensive range of quantitative retinal traits and their relation-
ship with incident cardiovascular events in a large longitudinal
study of people with type 2 diabetes in the UK. We found that
increased arteriolar tortuosity and reduced fractal dimension
were associated with incident cerebrovascular events in
people with type 2 diabetes over 8 years’ follow-up.
Table 3 Association of AVR,
CRAE and CRVE with incident
CV events in Cox regression
analyses
Event AVR CRAE CRVE
HR 95% CI p value HR 95% CI p value HR 95% CI p value
Any CV event (n=200)
Model A 0.39 0.07, 2.32 0.30 0.97 0.94, 1.01 0.15 0.99 0.96, 1.01 0.56
Model B 0.38 0.07, 2.22 0.29 0.98 0.94, 1.01 0.34 0.99 0.97, 1.02 0.92
Model C 0.49 0.09, 2.83 0.43 0.97 0.93, 1.00 0.09 0.98 0.96, 1.01 0.24
Coronary events (n=139)
Model A 0.42 0.05, 3.59 0.43 0.97 0.93, 1.02 0.32 0.99 0.96, 1.02 0.68
Model B 0.41 0.05, 3.33 0.41 0.98 0.94, 1.03 0.53 1.00 0.96, 1.03 0.99
Model C 0.56 0.07, 4.58 0.59 0.97 0.93, 1.02 0.19 0.98 0.94, 1.01 0.28
Cerebrovascular events (n=61)
Model A 0.32 0.01, 8.19 0.49 0.96 0.90, 1.03 0.28 0.98 0.94, 1.03 0.67
Model B 0.33 0.01, 8.11 0.50 0.97 0.91, 1.04 0.42 0.99 0.94, 1.04 0.88
Model C 0.34 0.01, 8.23 0.52 0.96 0.90, 1.03 0.49 0.99 0.94, 1.04 0.66
Model A: unadjusted. Model B: basic model adjusted for sex and age. Model C (multivariate, fully adjusted for
CV risk factors): adjusted for sex, age, duration of diabetes, systolic BP, HbA1c, total cholesterol, HDL-choles-
terol, smoking, prevalent baseline CVD, eGFR and diabetic retinopathy
CV, cardiovascular
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Although the association between fractal dimension and
cardiovascular risk factors in the general population [20] and
in people with type 1 diabetes [21] has been well documented,
few studies have focused on people with type 2 diabetes with
suboptimal retinal fractal dimension and cerebrovascular
events. In one study, decreased arteriolar and venular fractal
dimension were associated with stroke and its subtypes [22].
In a meta-analysis, narrower retinal arteriolar width and
decreased fractal dimension were associated with stroke
[23]. Interestingly, for these traits their direction of effect
was consistent with the findings of the ET2DS analysis.
Change in fractal dimension may reflect arteriovenous
differentiation after hypoxic signals during embryological
development of the retinal vasculature [24]. Previous studies
have found that pericyte apoptosis and activation of the renin–
angiotensin system are the leading early mechanisms of the
impact of diabetes on retinal microvasculature, because of the
increasing activation of Angiotensin II causing impaired cell
growth, angiogenesis and apoptosis, which may explain
decreased vascular density [25].
In our ET2DS dataset, increased arteriolar tortuosity was
also associated with incident cerebrovascular events. In a
cross-sectional study, increased arteriolar and venular tortuos-
ity were associated with ischaemic stroke in the general popu-
lation [22]. Results from the Norfolk Eye Study in the UK
showed that increased arteriolar tortuosity was associated with
prevalent stroke, with no association with prevalent myocar-
dial infarction [26]. Tortuous blood vessels are more common
in individuals with thrombosis in internal carotid artery,
atherosclerosis, hypertension, ageing and abdominal aortic
aneurysm [27]. Despite, contradictions in the findings of
decreased arteriolar tortuosity with hypertension and ageing
[28], the direction of effect for arteriolar tortuosity in our study
is consistent with previous epidemiological evidence and
supports grounds for explanation of the findings.
There is currently no exact pathophysiological mechanism
to explain the changes seen in the retinal traits but they are
likely to be associated with multiple factors including haemo-
dynamic changes, structural changes and genetic alterations.
Mechanical buckling and the loss of mechanical instability
could initiate the development of arteriolar tortuosity.
Tortuosity in the microvasculature might be associated with
increased local stress and render atherosclerotic plaques prone
to rupture [29]. Interestingly, blood dynamics studies have
shown that, compared with the same sized tortuous venules,
flow in the arteries generated a higher amount of mural throm-
bi and platelet activation rate [30] in the microvasculature,
because vessel tortuosity (e.g. curvature, coils, twist and
kinks) can restrict or completely occlude the blood flowwhich
may result in stroke or CVD. Retinal microvasculature shares
embryological, anatomical, and regulatory characteristics with
that of the cerebral circulation [31, 32]. It is probable that
retinal changes match those in the cerebral vessels, explaining
the associations with stroke rather than other forms of CVD.
In a study, there was no link between lacunar stroke and
severe stage diabetic retinopathy, even though lacunar stroke
is regarded as a microvascular cerebral disease [33].
Prospectively, the presence of severe diabetic retinopathy
has been associated with incident cerebral infarction and
haemorrhagic stroke [34]. The underlying explanation of our
results may be that, rather than the typical signs of diabetic
retinopathy (e.g. mild retinopathy), more subtle and specific
changes in the retinal vascular architecture, such as changes in
tortuosity and sparser vascular network pattern (Figs 3 and 4,
respectively), are associated with cerebrovascular events,
highlighting their importance in cardiovascular disease [35].
We did not find any evidence of association of retinal width
parameters with coronary events, despite the association of
Table 4 Association of arteriolar tortuosity and fractal dimension traits
with incident CV events in Cox regression analyses
Event Arteriolar tortuosity Fractal dimension
HR 95% CI p value HR 95% CI p value
Any CV event (n=200)
Model A 1.05 0.93, 1.18 0.42 0.89 0.77, 1.02 0.10
Model B 1.05 0.93, 1.19 0.39 0.90 0.78, 1.03 0.15
Model C 1.05 0.92, 1.19 0.44 0.91 0.79, 1.05 0.24
Model D 1.04 0.92, 1.18 0.55 0.89 0.77, 1.02 0.11
Coronary events (n=139)
Model A 0.97 0.83, 1.12 0.67 0.97 0.82, 1.14 0.73
Model B 0.97 0.84, 1.12 0.71 0.98 0.83, 1.16 0.87
Model C 0.96 0.82, 1.12 0.61 0.99 0.83, 1.18 0.98
Model D 0.95 0.82, 1.11 0.54 0.97 0.81, 1.16 0.75
Cerebrovascular events (n=61)
Model A 1.26 1.02, 1.57 0.03 0.73 0.57, 0.94 0.01
Model B 1.27 1.02, 1.58 0.03 0.74 0.57, 0.95 0.02
Model C 1.26 1.01, 1.58 0.04 0.73 0.56, 0.94 0.02
Model D 1.26 1.01, 1.58 0.04 0.73 0.57, 0.95 0.01
Model E 1.24 0.98, 1.57 0.07 0.71 0.54, 0.92 0.01
Stroke events (n=49)
Model A 1.29 1.01, 1.65 0.04 0.72 0.55, 0.96 0.02
Model B 1.30 1.01, 1.66 0.03 0.73 0.56, 0.97 0.03
Model C 1.31 1.01, 1.69 0.04 0.73 0.54, 0.96 0.03
Model D 1.31 1.01, 1.68 0.04 0.72 0.54, 0.97 0.02
Model E 1.28 0.98, 1.68 0.07 0.70 0.51, 0.94 0.02
Tortuosity variable is presented and was loge transformed. Fractal dimen-
sion has been rank transformed. Model A: unadjusted. Model B: adjusted
for sex and age. Model C: adjusted for sex, age, duration of diabetes,
systolic BP, HbA1c, total cholesterol, HDL-cholesterol, smoking, preva-
lent baseline CVD, eGFR. Model D (multivariate, fully adjusted for CV























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































narrower arterioles with incident cardiovascular events in
women but not in men in the general population [10, 36].
Coronary microvascular dysfunction is frequently present in
the absence of epicardial atherosclerosis (predominantly in
women) [37], and non-obstructive microvascular disease is
an independent risk factor for adverse cardiovascular events
[10]. Once epicardial coronary disease becomes apparent, as is
more often the case in higher risk men or people with type 2
diabetes, retinal vessel widths are less likely to be useful in
predicting cardiovascular events.
The strengths of this study include a longitudinal analysis
in a well characterised dataset with exceptionally long diabe-
tes duration and ~8 years follow-up, enabling multivariable
adjustment. This study also benefited from representative-
ness of type 2 diabetes population. We have a dataset
with established protocol and high-quality data collection.
At baseline, variables including diabetic retinopathy were
characterised using routine data from high quality sources
and standard operating procedures, and a systemic
approach for assessing cardiovascular events, which
ensured minimised loss to follow-up for cardiovascular
events. High quality digital fundus images were analysed
employing semi-automatic retinal vessel software
VAMPIRE, which has shown reliable results in previous
studies and has been useful for identifying biomarkers and
association with cardiovascular risk factors and complica-
tions in people with type 2 diabetes [38]. The unique
advantage of analysing retinal quantitative parameters over
Fig. 1 Kaplan–Meier curve demonstrating cumulative incidence of cere-
brovascular events stratified according to baseline arteriolar tortuosity
tertiles (loge transformed). Blue line, tertile 1; green line, tertile 2; brown
line, tertile 3
Fig. 2 Kaplan–Meier curve demonstrating cumulative incidence of cere-
brovascular events stratified according to baseline fractal dimension
tertiles (rank transformed). Blue line, tertile 1; green line, tertile 2; brown
line, tertile 3
Fig. 3 Retinal fundus photographs assessed quantitatively by VAMPIRE
software. In these figures, the venules are thicker and have a darker shade
of redwhile the arterioles are thinner with a lighter shade of red. (a) Image
with low value of arteriolar tortuosity. (b) Image with high value of
arteriolar tortuosity. Both images were taken from ET2DS
Diabetologia
other biomarkers is that the retinal assessment directly
reflects the microvasculature changes.
Our study also has some limitations. Replication and vali-
dation of these findings in another larger study of individuals
with type 2 diabetes is warranted. It would be ideal to conduct
this analysis in a prospective cohort of individuals with newly
diagnosed diabetes without prevalent cardiovascular events in
order to capture early vascular changes and to confirm tempo-
ral effects of the quantitative retinal parameters. The number
of studies reporting quantitative retinal traits has increased
greatly but there has not been homogeneity in findings, likely
arising from a lack of standardisation in the algorithms and
methods used across different analysis software. McGrory
et al. [39] found poor agreement between software, although
results with cardiovascular factors seemed application
independent.
While quantitative retinal parameters could potentially be
used along with other non-traditional and traditional cardio-
vascular risk factors for the stratification of cerebrovascular
risk, the increment in C statistic, which we found when retinal
parameters were added to a model already containing a range
of traditional risk factors, was relatively small. Although a
modest increase in C statistic is consistent with findings from
other studies on vascular risk prediction and may be related to
the insensitivity of the C statistic when used in this context
[40], our findings do not support immediate incorporation of
the parameters into risk prediction scores. Further investiga-
tion on the potential clinical utility of these parameters, includ-
ing better understanding of vascular aetiologies and measure-
ment in clinical trials, may improve predictive ability.
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